Sarepta Therapeutic's (SRPT) Price Target Raised to $90 at JMP Securities
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
JMP Securities maintained a Market Outperform rating on Sarepta Therapeutic (NASDAQ: SRPT) and raised its price target to $90.00 (from $60.00)
Shares of Sarepta Therapeutic closed at $59.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) Target of Cautious Article
- New Oriental Education (EDU) PT Raised to $60 at Brean Capital
- Stifel Remains Sidelined on Crane Co. (CR) Following Earnings Call
Create E-mail Alert Related CategoriesAnalyst PT Change
Related EntitiesJMP Securities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!